Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
出版年份 2017 全文链接
标题
Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
作者
关键词
-
出版物
PHARMACOGENOMICS JOURNAL
Volume 18, Issue 1, Pages 113-120
出版商
Springer Nature
发表日期
2017-01-24
DOI
10.1038/tpj.2016.94
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population
- (2016) De-Liang Shen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Ticagrelor versus clopidogrel in Asian patients with acute coronary syndrome: A retrospective analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial
- (2015) Hyun-Jae Kang et al. AMERICAN HEART JOURNAL
- Review of pharmacoeconomic evaluation of genotype-guided antiplatelet therapy
- (2015) Minghuan Jiang et al. EXPERT OPINION ON PHARMACOTHERAPY
- Influence ofCYP2C19loss-of-function variants on the metabolism of clopidogrel in patients from north-western China
- (2015) R. Lin et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy in acute coronary syndrome patients
- (2015) Minghuan Jiang et al. Pharmacogenetics and Genomics
- Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions
- (2015) O Alagoz et al. PHARMACOGENOMICS JOURNAL
- Thresholds for the cost–effectiveness of interventions: alternative approaches
- (2015) Elliot Marseille et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies in Acute Coronary Syndrome
- (2014) Dhruv S. Kazi et al. ANNALS OF INTERNAL MEDICINE
- World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
- (2014) Glenn N. Levine et al. Nature Reviews Cardiology
- Cost-Effectiveness of Universal and Platelet Reactivity Assay-Driven Antiplatelet Therapy in Acute Coronary Syndrome
- (2013) Craig I. Coleman et al. AMERICAN JOURNAL OF CARDIOLOGY
- The CYP2C19 genotype does not impact the long-term prognosis of patients with coronary artery disease
- (2013) Yong Peng et al. ATHEROSCLEROSIS
- Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study
- (2013) Payal Kohli et al. CIRCULATION
- Challenges and Limitations in the Interpretation of Systematic Reviews: Making Sense of Clopidogrel and CYP2C19 Pharmacogenetics
- (2013) M J Sorich et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Asia-Pacific Evaluation of Cardiovascular Therapies (ASPECT) Collaboration —Improving the quality of cardiovascular care in the Asia Pacific Region
- (2013) Christopher M. Reid et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Relationship between Cytochrome P450 2C19*2 Polymorphism and Stent Thrombosis following Percutaneous Coronary Intervention in Chinese Patients Receiving Clopidogrel
- (2013) Y Luo et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Cost–effectiveness of using CYP2C19 genotype to guide selection of clopidogrel or ticagrelor in Australia
- (2013) Michael J Sorich et al. PHARMACOGENOMICS
- CYP2C19 Phenotype, Stent Thrombosis, Myocardial Infarction, and Mortality in Patients with Coronary Stent Placement in a Chinese Population
- (2013) Xiang Xie et al. PLoS One
- Cost-effectiveness of treating acute coronary syndrome patients with ticagrelor for 12 months: results from the PLATO study
- (2012) Elisabet Nikolic et al. EUROPEAN HEART JOURNAL
- Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention
- (2012) Xiao-Fang Tang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Polymorphisms and Drug Interactions Leading to Clopidogrel Resistance: Why the Asian Population Requires Special Attention
- (2012) Md. Shariful Hasan et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Genetic testing in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cost-effectiveness analysis
- (2012) A. LALA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes
- (2012) Laura Panattoni et al. PHARMACOECONOMICS
- Cost-Effectiveness of Cytochrome P450 2C19 Genotype Screening for Selection of Antiplatelet Therapy with Clopidogrel or Prasugrel
- (2012) Emily S. Reese et al. PHARMACOTHERAPY
- Association between cytochrome P450 2C19 polymorphism and clinical outcomes in Chinese patients with coronary artery disease
- (2011) Mao Chen et al. ATHEROSCLEROSIS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
- (2011) S A Scott et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ticagrelor versus Genotype-Driven Antiplatelet Therapy for Secondary Prevention after Acute Coronary Syndrome: A Cost-Effectiveness Analysis
- (2011) Daniel J. Crespin et al. VALUE IN HEALTH
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- The Risk of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Bare-Metal and Drug-Eluting Stents
- (2009) Neville Kukreja et al. JACC-Cardiovascular Interventions
- Clinical outcome after acute coronary syndrome in Japanese patients: An observational cohort study
- (2009) Michinari Nakamura et al. Journal of Cardiology
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Future of Health Technology Assessment in Healthcare Decision Making in Asia
- (2009) Bong-Min Yang PHARMACOECONOMICS
- Development and Validation of an All-Cause Mortality Risk Score in Type 2 DiabetesThe Hong Kong Diabetes Registry
- (2008) Xilin Yang ARCHIVES OF INTERNAL MEDICINE
- Cost-Effectiveness of Providing Full Drug Coverage to Increase Medication Adherence in Post–Myocardial Infarction Medicare Beneficiaries
- (2008) Niteesh K. Choudhry et al. CIRCULATION
- Balancing the Risks of Restenosis and Stent Thrombosis in Bare-Metal Versus Drug-Eluting Stents
- (2008) Pallav Garg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
- (2008) Scott D Grosse Expert Review of Pharmacoeconomics & Outcomes Research
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
- (2007) Spencer B. King et al. CIRCULATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now